Aehr Test Systems's next confirmed earnings release is scheduled for October 22, 2026.
| Earnings Date | 10/22/2026 |
As of May 31, 2026, Aehr Test Systems has 32.48M shares outstanding.
| Shares Outstanding | 32.48M |
As of May 31, 2026, Aehr Test Systems maintains a current ratio of 10.33, meaning it holds 10.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 10.33 |
| Quick Ratio | 7.50 |
| Debt / Equity | 4.50 |
| Debt / EBITDA | -0.93 |
Over the twelve months ended May 31, 2026, Aehr Test Systems posted a negative return on equity (ROE) of -4.16, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -3.61, reflecting losses generated across the asset base. The company generates approximately 314,218.74 in revenue per employee across its workforce of 136.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.78 indicates how many times Aehr Test Systems sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -4.16 |
| Return on Assets (ROA) | -3.61 |
| Revenue Per Employee | 314,218.74 |
| Employee Count | 136.50 |
| Inventory Turnover | 0.78 |
Over the twelve months ended May 31, 2026, Aehr Test Systems recorded an income tax benefit of -3.95M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -10.07M and -6.11M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | -3.95M |
Over the twelve months ended May 31, 2026, Aehr Test Systems generated 42.89M in revenue and converted that into -6.11M in net income, yielding earnings per share of -0.20. EBITDA reached -9.11M, while operating income came in at -12.13M.
| Revenue | 42.89M |
| Gross Profit | 15.14M |
| Operating Income | -12.13M |
| Pretax Income | -10.07M |
| Net Income | -6.11M |
| EBITDA | -9.11M |
| EBIT | -12.14M |
| Earnings Per Share (EPS) | -0.20 |
As of May 31, 2026, Aehr Test Systems holds 99.81M in cash and equivalents against 8.48M in total debt, resulting in a net debt position of -99.81M. Total book value stands at 188.30M, with working capital of 142.90M providing operational flexibility.
| Cash & Cash Equivalents | 99.81M |
| Total Debt | 8.48M |
| Net Debt | -99.81M |
| Equity (Book Value) | 188.30M |
| Book Value Per Share | 5.80 |
| Working Capital | 142.90M |
Aehr Test Systems produced -2.84M in operating cash flow over the twelve months ended May 31, 2026. After subtracting -1.77M in capital expenditures, free cash flow totaled -4.61M - equivalent to -0.15 per share.
| Operating Cash Flow | -2.84M |
| Capital Expenditures | -1.77M |
| Free Cash Flow | -4.61M |
| FCF Per Share | -0.15 |
Over the twelve months ended May 31, 2026, Aehr Test Systems posted a gross margin of 35.30, reflecting its pricing power and cost economics. The operating margin of -28.29 and net profit margin of -14.25 provide insight into operational efficiency.
| Gross Margin | 35.30 |
| Operating Margin | -28.29 |
| Pretax Margin | -23.47 |
| Profit Margin | -14.25 |
| EBITDA Margin | -21.24 |